Eyre, T., Phillips, E., Linton, K., Kassam, S., Gibb, A., Allibone, S., . . . Collins, G. (2017). Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting. Wiley.
Chicago-referens (17:e uppl.)Eyre, T., et al. Results of a Multicentre UK-wide Retrospective Study Evaluating the Efficacy of Brentuximab Vedotin in Relapsed, Refractory Classical Hodgkin Lymphoma in the Transplant Naive Setting. Wiley, 2017.
MLA-referens (9:e uppl.)Eyre, T., et al. Results of a Multicentre UK-wide Retrospective Study Evaluating the Efficacy of Brentuximab Vedotin in Relapsed, Refractory Classical Hodgkin Lymphoma in the Transplant Naive Setting. Wiley, 2017.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.